{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:20:38Z","timestamp":1793132438272,"version":"4.5.0"},"reference-count":127,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T00:00:00Z","timestamp":1563408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.01677","type":"journal-article","created":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T13:37:45Z","timestamp":1563457065000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":98,"title":["Protective Antibodies Against Influenza Proteins"],"prefix":"10.3389","volume":"10","author":[{"given":"Herbey O.","family":"Padilla-Quirarte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delia V.","family":"Lopez-Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes","family":"Gutierrez-Xicotencatl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Esquivel-Guadarrama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,7,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nri1783","article-title":"Antiviral antibody responses: the two extremes of a wide spectrum","volume":"6","author":"Hangartner","year":"2006","journal-title":"Nat Rev Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/nrmicro2613","article-title":"Influenza A viruses: new research developments","volume":"9","author":"Medina","year":"2011","journal-title":"Nat Rev Microbiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1006\/viro.1993.1473","article-title":"Molecular assembly of influenza virus: association of the NS2 protein with virion matrix","volume":"196","author":"Yasuda","year":"1993","journal-title":"Virology."},{"key":"B4","first-page":"153","article-title":"Influenza A: understanding the viral life cycle","volume":"82","author":"Samji","year":"2009","journal-title":"Yale J Biol Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1016\/j.str.2015.08.007","article-title":"Structural basis for a novel interaction between the NS1 protein derived from the 1918 influenza virus and RIG-I","volume":"23","author":"Jureka","year":"2015","journal-title":"Structure"},{"key":"B6","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.tim.2017.12.006","article-title":"Immunomodulatory nonstructural proteins of influenza A viruses","volume":"26","author":"Klemm","year":"2018","journal-title":"Trends Microbiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1038\/nm1201-1306","article-title":"A novel influenza A virus mitochondrial protein that induces cell death","volume":"7","author":"Chen","year":"2001","journal-title":"Nat Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/ni1343","article-title":"Influenza and the challenge for immunology","volume":"7","author":"Doherty","year":"2006","journal-title":"Nat Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1750-2659.2008.00053.","article-title":"FluBlok, a recombinant hemagglutinin influenza vaccine","volume":"2","author":"Cox","year":"2008","journal-title":"Influenza Other Respir Viruses."},{"key":"B10","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1128\/CMR.00097-12","article-title":"Traditional and new influenza vaccines","volume":"26","author":"Wong","year":"2013","journal-title":"Clin Microbiol Rev."},{"key":"B11","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1084\/jem.20080979","article-title":"Dual role for B-1a cells in immunity to influenza virus infection","volume":"205","author":"Choi","year":"2008","journal-title":"J Exp Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1084\/jem.192.2.271","article-title":"B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection","volume":"192","author":"Baumgarth","year":"2000","journal-title":"J Exp Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/imr.12094","article-title":"How specific is too specific? B-cell responses to viral infections reveal the importance of breadth over depth","volume":"255","author":"Baumgarth","year":"2013","journal-title":"Immunol Rev."},{"key":"B14","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.1128\/JVI.02128-06","article-title":"Natural antibody and complement mediate neutralization of influenza virus in the absence of prior immunity","volume":"81","author":"Jayasekera","year":"2007","journal-title":"J Virol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/82_2014_425","article-title":"B cell responses to influenza infection and vaccination","volume":"386","author":"Chiu","year":"2015","journal-title":"Curr Top Microbiol Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.it.2016.10.003","article-title":"Antigen Presentation to B Cells","volume":"37","author":"Heesters","year":"2016","journal-title":"Trends Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"5827","DOI":"10.4049\/jimmunol.175.9.5827","article-title":"CD4 T cell-independent antibody response promotes resolution of primary influenza infection and helps to prevent reinfection","volume":"175","author":"Lee","year":"2005","journal-title":"J Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/nri3802","article-title":"Memory B cells","volume":"15","author":"Kurosaki","year":"2015","journal-title":"Nat Rev Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1084\/jem.192.6.813","article-title":"Intrinsic constraint on plasmablast growth and extrinsic limits of plasma cell survival","volume":"192","author":"Sze","year":"2000","journal-title":"J Exp Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1126\/science.1218888","article-title":"Seroevidence for H5N1 influenza infections in humans: meta-analysis","volume":"335","author":"Wang","year":"2012","journal-title":"Science."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1056\/NEJMoa1304459","article-title":"Human infection with a novel avian-origin influenza A (H7N9) virus","volume":"368","author":"Gao","year":"2013","journal-title":"N Engl J Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/0092-8674(82)90135-0","article-title":"The antigenic structure of the influenza virus A\/PR\/8\/34 hemagglutinin (H1 subtype)","volume":"31","author":"Caton","year":"1982","journal-title":"Cell"},{"key":"B23","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/0042-6822(81)90136-7","article-title":"Topological mapping antigenic sites on the influenza A\/PR\/8\/34 virus hemagglutinin using monoclonal antibodies","volume":"113","author":"Lubeck","year":"1981","journal-title":"Virology."},{"key":"B24","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1146\/annurev.mi.35.100181.001153","article-title":"Antigenic characterization of viruses by monoclonal antibodies","volume":"35","author":"Yewdell","year":"1981","journal-title":"Annu Rev Microbiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/290713a0","article-title":"Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies","volume":"290","author":"Gerhard","year":"1981","journal-title":"Nature."},{"key":"B26","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/ni.3680","article-title":"Defining B cell immunodominance to viruses","volume":"18","author":"Angeletti","year":"2017","journal-title":"Nat Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"4992","DOI":"10.1172\/JCI122895","article-title":"Antigenic sites in influenza H1 hemagglutinin display species-specific immunodominance","volume":"128","author":"Liu","year":"2018","journal-title":"J Clin Invest."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e01100","DOI":"10.1128\/JVI.01100-18","article-title":"Immunodominance of antigenic site B in the hemagglutinin of the current H3N2 influenza virus in humans and mice","volume":"92","author":"Broecker","year":"2018","journal-title":"J Virol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e01673","DOI":"10.1128\/JVI.01673-18","article-title":"Antibody responses toward the major antigenic sites of influenza B virus hemagglutinin in mice, ferrets, and humans","volume":"93","author":"Sun","year":"2019","journal-title":"J Virol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.virol.2016.10.024","article-title":"Influenza A virus hemagglutinin specific antibodies interfere with virion neuraminidase activity via two distinct mechanisms","volume":"500","author":"Kosik","year":"2017","journal-title":"Virology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1128\/mBio.02281-16","article-title":"Analysis of anti-influenza virus neuraminidase antibodies in children, adults, and the elderly by ELISA and enzyme inhibition: evidence for original antigenic sin","volume":"8","author":"Rajendran","year":"2017","journal-title":"MBio"},{"key":"B32","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1128\/JVI.02275-15","article-title":"Hemagglutinin stalk- and neuraminidase-specific monoclonal antibodies protect against lethal H10N8 influenza virus infection in mice","volume":"90","author":"Wohlbold","year":"2016","journal-title":"J Virol."},{"key":"B33","first-page":"572","article-title":"On the Doctrine of Original Antigenic Sin","volume":"104","author":"Francis","year":"1960","journal-title":"Proc Am Philos Soc."},{"key":"B34","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1084\/jem.124.3.331","article-title":"Disquisitions of Original Antigenic Sin. I. Evidence in man","volume":"124","author":"Fazekas de","year":"1966","journal-title":"J Exp Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.coviro.2016.12.004","article-title":"Immune history and influenza virus susceptibility","volume":"22","author":"Cobey","year":"2017","journal-title":"Curr Opin Virol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1098\/rsif.2015.0627","article-title":"A simple mechanistic explanation for original antigenic sin and its alleviation by adjuvants","volume":"12","author":"Ndifon","year":"2015","journal-title":"J R Soc Interface"},{"key":"B37","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1126\/science.1186430","article-title":"Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus","volume":"328","author":"Xu","year":"2010","journal-title":"Science."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1056\/NEJMoa0906453","article-title":"Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus","volume":"361","author":"Hancock","year":"2009","journal-title":"N Engl J Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1128\/JVI.02184-09","article-title":"Naturally occurring human monoclonal antibodies neutralize both 1918 and 2009 pandemic influenza A (H1N1) viruses","volume":"84","author":"Krause","year":"2010","journal-title":"J Virol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"e1005806","DOI":"10.1371\/journal.ppat.1005806","article-title":"Antibodies with 'original antigenic sin' properties are valuable components of secondary immune responses to influenza viruses","volume":"12","author":"Linderman","year":"2016","journal-title":"PLoS Pathog."},{"key":"B41","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/nature06890","article-title":"Rapid cloning of high-affinity human monoclonal antibodies against influenza virus","volume":"453","author":"Wrammert","year":"2008","journal-title":"Nature."},{"key":"B42","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1128\/CVI.00790-13","article-title":"Humans and ferrets with prior H1N1 influenza virus infections do not exhibit evidence of original antigenic sin after infection or vaccination with the 2009 pandemic H1N1 influenza virus","volume":"21","author":"O'Donnell","year":"2014","journal-title":"Clin Vaccine Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e1000350","DOI":"10.1371\/journal.ppat.1000350","article-title":"Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses","volume":"5","author":"Yoshida","year":"2009","journal-title":"PLoS Pathog."},{"key":"B44","doi-asserted-by":"publisher","first-page":"14216","DOI":"10.1073\/pnas.1111497108","article-title":"Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin","volume":"108","author":"Whittle","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"B45","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/nature11414","article-title":"Cross-neutralization of influenza A viruses mediated by a single antibody loop","volume":"489","author":"Ekiert","year":"2012","journal-title":"Nature."},{"key":"B46","doi-asserted-by":"publisher","first-page":"11048","DOI":"10.1128\/JVI.05397-11","article-title":"Naturally occurring antibodies in humans can neutralize a variety of influenza virus strains, including H3, H1, H2, and H5","volume":"85","author":"Ohshima","year":"2011","journal-title":"J Virol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"6743","DOI":"10.1128\/JVI.03562-13","article-title":"A broadly neutralizing human monoclonal antibody directed against a novel conserved epitope on the influenza virus H3 hemagglutinin globular head","volume":"88","author":"Benjamin","year":"2014","journal-title":"J Virol."},{"key":"B48","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1128\/JVI.67.5.2552-2558.1993","article-title":"A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains","volume":"67","author":"Okuno","year":"1993","journal-title":"J Virol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1126\/science.1205669","article-title":"A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins","volume":"333","author":"Corti","year":"2011","journal-title":"Science."},{"key":"B50","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1126\/science.1204839","article-title":"A highly conserved neutralizing epitope on group 2 influenza A viruses","volume":"333","author":"Ekiert","year":"2011","journal-title":"Science."},{"key":"B51","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1126\/science.1171491","article-title":"Antibody recognition of a highly conserved influenza virus epitope","volume":"324","author":"Ekiert","year":"2009","journal-title":"Science."},{"key":"B52","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.coviro.2012.02.005","article-title":"Broadly neutralizing antibodies against influenza virus and prospects for universal therapies","volume":"2","author":"Ekiert","year":"2012","journal-title":"Curr Opin Virol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"e1004103","DOI":"10.1371\/journal.ppat.1004103","article-title":"Molecular signatures of hemagglutinin stem-directed heterosubtypic human neutralizing antibodies against influenza A viruses","volume":"10","author":"Avnir","year":"2014","journal-title":"PLoS Pathog."},{"key":"B54","doi-asserted-by":"publisher","first-page":"20842","DOI":"10.1038\/srep20842","article-title":"IGHV1-69 polymorphism modulates anti-influenza antibody repertoires, correlates with IGHV utilization shifts and varies by ethnicity","volume":"6","author":"Avnir","year":"2016","journal-title":"Sci Rep"},{"key":"B55","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ebiom.2017.03.007","article-title":"A broadly reactive human anti-hemagglutinin stem monoclonal antibody that inhibits influenza A virus particle release","volume":"17","author":"Yamayoshi","year":"2017","journal-title":"EBioMedicine"},{"key":"B56","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1128\/mBio.00150-11","article-title":"Why do influenza virus subtypes die out? A hypothesis","volume":"2","author":"Palese","year":"2011","journal-title":"MBio"},{"key":"B57","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/ni.3684","article-title":"Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins","volume":"8","author":"Nachbagauer","year":"2017","journal-title":"Nat Immunol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13073-015-0239-y","article-title":"Longitudinal analysis of the peripheral B cell repertoire reveals unique effects of immunization with a new influenza virus strain","volume":"7","author":"Cortina-Ceballos","year":"2015","journal-title":"Genome Med"},{"key":"B59","doi-asserted-by":"publisher","first-page":"9047","DOI":"10.1073\/pnas.1118979109","article-title":"Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells","volume":"109","author":"Li","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"B60","doi-asserted-by":"publisher","first-page":"316ra192","DOI":"10.1126\/scitranslmed.aad0522","article-title":"Immune history profoundly affects broadly protective B cell responses to influenza","volume":"7","author":"Andrews","year":"2015","journal-title":"Sci Transl Med."},{"key":"B61","doi-asserted-by":"publisher","first-page":"e1005702","DOI":"10.1371\/journal.ppat.1005702","article-title":"Two escape mechanisms of influenza A virus to a broadly neutralizing stalk-binding antibody","volume":"12","author":"Chai","year":"2016","journal-title":"PLoS Pathog."},{"key":"B62","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1750-2659.2011.00304.x","article-title":"Influenza neuraminidase","volume":"6","author":"Air","year":"2012","journal-title":"Influenza Other Respir Viruses."},{"key":"B63","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1128\/JVI.2.8.778-786.1968","article-title":"Protective effects of specific immunity to viral neuraminidase on influenza virus infection of mice","volume":"2","author":"Schulman","year":"1968","journal-title":"J Virol."},{"key":"B64","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1128\/JVI.2.7.761-762.1968","article-title":"Antibody response in man to influenza virus neuraminidase following influenza","volume":"2","author":"Kilbourne","year":"1968","journal-title":"J Virol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1056\/NEJM197206222862502","article-title":"Association of serum anti-neuraminidase antibody with resistance to influenza in man","volume":"286","author":"Murphy","year":"1972","journal-title":"N Engl J Med."},{"key":"B66","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.cell.2018.03.030","article-title":"Influenza infection in humans induces broadly cross-reactive and protective neuraminidase-reactive antibodies","author":"Chen","year":"2018","journal-title":"Cell."},{"key":"B67","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/rmv.1713","article-title":"Contribution of antibody production against neuraminidase to the protection afforded by influenza vaccines","volume":"22","author":"Marcelin","year":"2012","journal-title":"Rev Med Virol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/82_2014_398","article-title":"Influenza neuraminidase as a vaccine antigen","volume":"386","author":"Eichelberger","year":"2015"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1086\/657084","article-title":"Inactivated seasonal influenza vaccines increase serum antibodies to the neuraminidase of pandemic influenza A(H1N1) 2009 virus in an age-dependent manner","volume":"202","author":"Marcelin","year":"2010","journal-title":"J Infect Dis."},{"key":"B70","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/S0140-6736(73)92196-X","article-title":"Effect of neuraminidase antibody on Hong Kong influenza","volume":"1","author":"Monto","year":"1973","journal-title":"Lancet."},{"key":"B71","doi-asserted-by":"publisher","first-page":"405","DOI":"10.4161\/hv.22908","article-title":"Correlates of protection to influenza virus where do we go from here?","volume":"9","author":"Cox","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"B72","doi-asserted-by":"publisher","first-page":"e00417","DOI":"10.1128\/mBio.00417-16","article-title":"Evaluation of antihemagglutinin and antineuraminidase antibodies as correlates of protection in an influenza A\/H1N1 virus healthy human challenge model","volume":"7","author":"Memoli","year":"2016","journal-title":"MBio."},{"key":"B73","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1093\/infdis\/jis935","article-title":"Antibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to the neuraminidase","volume":"207","author":"Couch","year":"2013","journal-title":"J Infect Dis."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1093\/infdis\/jiv195","article-title":"Antibody to influenza virus neuraminidase: an independent correlate of protection","volume":"212","author":"Monto","year":"2015","journal-title":"J Infect Dis."},{"key":"B75","doi-asserted-by":"publisher","first-page":"e02556","DOI":"10.1128\/mBio.02556-14","article-title":"Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice","volume":"6","author":"Wohlbold","year":"2015","journal-title":"MBio."},{"key":"B76","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1371\/journal.pmed.0040059","article-title":"Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans","volume":"4","author":"Sandbulte","year":"2007","journal-title":"PLoS Med."},{"key":"B77","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1371\/journal.pmed.0040091","article-title":"Can immunity induced by the human influenza virus N1 neuraminidase provide some protection from avian influenza H5N1 viruses?","volume":"4","author":"Gillim-Ross","year":"2007","journal-title":"PLoS Med."},{"key":"B78","first-page":"189","article-title":"Difficulties in standardizing the neuraminidase content of influenza vaccines","volume":"98","author":"G\u00e9rentes","year":"1999","journal-title":"Dev Biol Stand"},{"key":"B79","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/irv.12001","article-title":"Label-free mass spectrometry-based quantification of hemagglutinin and neuraminidase in influenza virus preparations and vaccines","volume":"7","author":"Getie-Kebtie","year":"2013","journal-title":"Influenza Other Respir Viruses."},{"key":"B80","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1128\/JVI.67.10.5721-5723.1993","article-title":"Dissociation of influenza virus hemagglutinin and neuraminidase eliminates their intravirionic antigenic competition","volume":"67","author":"Johansson","year":"1993","journal-title":"J Virol."},{"key":"B81","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1128\/JVI.63.3.1239-1246.1989","article-title":"Purified influenza virus hemagglutinin and neuraminidase are equivalent in stimulation of antibody response but induce contrasting types of immunity to infection","volume":"63","author":"Johansson","year":"1989","journal-title":"J Virol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1128\/mBio.02332-17","article-title":"NAction! how can neuraminidase-based immunity contribute to better influenza virus vaccines?","volume":"9","author":"Krammer","year":"2018","journal-title":"MBio"},{"key":"B83","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1172\/JCI84428","article-title":"Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection","volume":"126","author":"DiLillo","year":"2016","journal-title":"J Clin Invest."},{"key":"B84","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nm.3443","article-title":"Broadly neutralizing hemagglutinin stalk-specific antibodies require FcgammaR interactions for protection against influenza virus in vivo","volume":"20","author":"DiLillo","year":"2014","journal-title":"Nat Med."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1093\/infdis\/jit294","article-title":"Age-associated cross-reactive antibody-dependent cellular cytotoxicity toward 2009 pandemic influenza A virus subtype H1N1","volume":"208","author":"Jegaskanda","year":"2013","journal-title":"J Infect Dis."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.4049\/jimmunol.1201574","article-title":"Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity antibodies in the absence of neutralizing antibodies","volume":"190","author":"Jegaskanda","year":"2013","journal-title":"J Immunol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1093\/infdis\/jiw629","article-title":"Induction of H7N9-cross-reactive antibody-dependent cellular cytotoxicity antibodies by human seasonal influenza A viruses that are directed toward the nucleoprotein","volume":"215","author":"Jegaskanda","year":"2017","journal-title":"J Infect Dis."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1093\/infdis\/jiv181","article-title":"High antibody-dependent cellular cytotoxicity antibody titers to H5N1 and H7N9 avian influenza A viruses in healthy US adults and older children","volume":"212","author":"Terajima","year":"2015","journal-title":"J Infect Dis."},{"key":"B89","doi-asserted-by":"publisher","first-page":"469","DOI":"10.4049\/jimmunol.1400432","article-title":"Influenza-specific antibody-dependent cellular cytotoxicity: toward a universal influenza vaccine","volume":"193","author":"Jegaskanda","year":"2014","journal-title":"J Immunol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"e0154461","DOI":"10.1371\/journal.pone.0154461","article-title":"Influenza-specific antibody-dependent phagocytosis","volume":"11","author":"Ana-Sosa-Batiz","year":"2016","journal-title":"PLoS ONE."},{"key":"B91","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1128\/mBio.01624-16","article-title":"Broadly neutralizing hemagglutinin stalk-specific antibodies induce potent phagocytosis of immune complexes by neutrophils in an Fc-dependent manner","volume":"7","author":"Mullarkey","year":"2016","journal-title":"MBio"},{"key":"B92","doi-asserted-by":"publisher","first-page":"13463","DOI":"10.1128\/JVI.05193-11","article-title":"Complement-dependent lysis of influenza a virus-infected cells by broadly cross-reactive human monoclonal antibodies","volume":"85","author":"Terajima","year":"2011","journal-title":"J Virol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"3700","DOI":"10.1128\/JVI.02576-14","article-title":"Structure of the extracellular domain of matrix protein 2 of influenza A virus in complex with a protective monoclonal antibody","volume":"89","author":"Cho","year":"2015","journal-title":"J Virol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3390\/vaccines3010105","article-title":"M2e-based universal influenza A vaccines","volume":"3","author":"Deng","year":"2015","journal-title":"Vaccines"},{"key":"B95","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1128\/JVI.62.8.2762-2772.1988","article-title":"Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions","volume":"62","author":"Zebedee","year":"1988","journal-title":"J Virol."},{"key":"B96","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1128\/JVI.64.3.1375-1377.1990","article-title":"Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice","volume":"64","author":"Treanor","year":"1990","journal-title":"J Virol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/imm.12310","article-title":"Fc receptor is not required for inducing antibodies but plays a critical role in conferring protection after influenza M2 vaccination","volume":"143","author":"Lee","year":"2014","journal-title":"Immunology."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.4049\/jimmunol.0902147","article-title":"Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection","volume":"186","author":"El Bakkouri","year":"2011","journal-title":"J Immunol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"e0124677","DOI":"10.1371\/journal.pone.0124677","article-title":"A human anti-M2 antibody mediates antibody-dependent cell-mediated cytotoxicity (ADCC) and cytokine secretion by resting and cytokine-preactivated Natural Killer (NK) cells","volume":"10","author":"Simhadri","year":"2015","journal-title":"PLoS ONE."},{"key":"B100","doi-asserted-by":"publisher","first-page":"5598","DOI":"10.4049\/jimmunol.172.9.5598","article-title":"Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity","volume":"172","author":"Jegerlehner","year":"2004","journal-title":"J Immunol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.antiviral.2008.06.002","article-title":"Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein","volume":"80","author":"Wang","year":"2008","journal-title":"Antiviral Res."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/13484","article-title":"A universal influenza A vaccine based on the extracellular domain of the M2 protein","volume":"5","author":"Neirynck","year":"1999","journal-title":"Nat Med."},{"key":"B103","doi-asserted-by":"publisher","first-page":"5145","DOI":"10.1016\/j.vaccine.2011.05.041","article-title":"Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adults","volume":"29","author":"Turley","year":"2011","journal-title":"Vaccine."},{"key":"B104","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.antiviral.2017.01.021","article-title":"Consensus M2e peptide conjugated to gold nanoparticles confers protection against H1N1, H3N2 and H5N1 influenza A viruses","volume":"141","author":"Tao","year":"2017","journal-title":"Antiviral Res"},{"key":"B105","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.antiviral.2013.01.010","article-title":"Enhanced Influenza VLP vaccines comprising matrix-2 ectodomain and nucleoprotein epitopes protects mice from lethal challenge","volume":"98","author":"Gao","year":"2013","journal-title":"Antiviral Res."},{"key":"B106","doi-asserted-by":"publisher","first-page":"426","DOI":"10.3201\/eid1303.061125","article-title":"Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1","volume":"13","author":"Tompkins","year":"2007","journal-title":"Emerg Infect Dis."},{"key":"B107","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.bbrc.2017.09.011","article-title":"Roles of antibodies to influenza A virus hemagglutinin, neuraminidase, and M2e in conferring cross protection","volume":"493","author":"Kim","year":"2017","journal-title":"Biochem Biophys Res Commun."},{"key":"B108","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/1743-422X-3-102","article-title":"Influenza A virus infection engenders a poor antibody response against the ectodomain of matrix protein 2","volume":"3","author":"Feng","year":"2006","journal-title":"Virol J"},{"key":"B109","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1093\/infdis\/jit811","article-title":"Serum antibody response to matrix protein 2 following natural infection with 2009 pandemic influenza A(H1N1) virus in humans","volume":"209","author":"Zhong","year":"2014","journal-title":"J Infect Dis."},{"key":"B110","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1093\/infdis\/jiu539","article-title":"Efficacy and safety of treatment with an anti-m2e monoclonal antibody in experimental human influenza","volume":"211","author":"Ramos","year":"2015","journal-title":"J Infect Dis."},{"key":"B111","unstructured":"Comparative, Safety and Immunogenicity of 1,.0 \u03bcg Intramuscular (i.m.) and 2.0 \u03bcg Subcutaneous (s.c.) Dosing With VAX102 (M2e-flagellin) Universal Influenza Vaccine in Healthy Adults"},{"key":"B112","unstructured":"Safety, Study of Recombinant M2e Influenza-A Vaccine in Healthy Adults,"},{"key":"B113","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.1016\/j.vaccine.2015.04.073","article-title":"Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant region of hepatitis B core antigen: Broad protective efficacy of particles carrying four copies of M2e","volume":"33","author":"Tsybalova","year":"2015","journal-title":"Vaccine."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1007\/s00705-009-0479-5","article-title":"Antibodies to PB1-F2 protein are induced in response to influenza A virus infection","volume":"154","author":"Krejnusov\u00e1","year":"2009","journal-title":"Arch Virol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"9383","DOI":"10.1128\/JVI.01408-16","article-title":"Antigenic fingerprinting of antibody response in humans following exposure to highly pathogenic H7N7 avian influenza virus: evidence for Anti-PA-X antibodies","volume":"90","author":"Khurana","year":"2016","journal-title":"J Virol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.ebiom.2016.04.029","article-title":"What lies beneath: antibody dependent natural killer cell activation by antibodies to internal influenza virus proteins","volume":"8","author":"Vanderven","year":"2016","journal-title":"EBioMedicine"},{"key":"B117","doi-asserted-by":"publisher","first-page":"4331","DOI":"10.4049\/jimmunol.1003057","article-title":"Contributions of antinucleoprotein IgG to heterosubtypic immunity against influenza virus","volume":"186","author":"LaMere","year":"2011","journal-title":"J Immunol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"4168","DOI":"10.4049\/jimmunol.181.6.4168","article-title":"A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus","volume":"181","author":"Carragher","year":"2008","journal-title":"J Immunol."},{"key":"B119","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1128\/JVI.67.5.2723-2729.1993","article-title":"Analysis of the evolution and variation of the human influenza A virus nucleoprotein gene from 1933 to 1990","volume":"67","author":"Shu","year":"1993","journal-title":"J Virol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.immuni.2005.12.005","article-title":"Development of effective vaccines against pandemic influenza","volume":"24","author":"Subbarao","year":"2006","journal-title":"Immunity."},{"key":"B121","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1073\/pnas.82.6.1785","article-title":"Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes","volume":"82","author":"Yewdell","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"key":"B122","doi-asserted-by":"publisher","first-page":"454","DOI":"10.4049\/jimmunol.180.1.454","article-title":"B cells promote resistance to heterosubtypic strains of influenza via multiple mechanisms","volume":"180","author":"Rangel-Moreno","year":"2008","journal-title":"J Immunol."},{"key":"B123","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.4049\/jimmunol.126.5.1814","article-title":"Expression of influenza A virus internal antigens on the surface of infected P815 cells","volume":"126","author":"Yewdell","year":"1981","journal-title":"J Immunol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1128\/CVI.00339-13","article-title":"In vitro assessment of the immunological significance of a human monoclonal antibody directed to the influenza a virus nucleoprotein","volume":"20","author":"Bodewes","year":"2013","journal-title":"Clin Vaccine Immunol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/266052a0","article-title":"Early presence of ribonucleoprotein antigen on surface of influenza virus-infected cells","volume":"266","author":"Virelizier","year":"1977","journal-title":"Nature."},{"key":"B126","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1084\/jem.20131692","article-title":"Prolonged antigen presentation by immune complex-binding dendritic cells programs the proliferative capacity of memory CD8 T cells","volume":"211","author":"Le\u00f3n","year":"2014","journal-title":"J Exp Med."},{"key":"B127","doi-asserted-by":"publisher","first-page":"6153","DOI":"10.4049\/jimmunol.179.9.6153","article-title":"Rectification of age-associated deficiency in cytotoxic T cell response to influenza A virus by immunization with immune complexes","volume":"179","author":"Zheng","year":"2007","journal-title":"J Immunol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01677\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T10:53:50Z","timestamp":1695034430000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01677\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,18]]},"references-count":127,"alternative-id":["10.3389\/fimmu.2019.01677"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.01677","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,18]]},"article-number":"1677"}}